has been cited by the following article(s):
[1]
|
The Experience of Chemotherapy-induced Peripheral Neuropathy in People with Cancer
Asian Oncology Nursing,
2019
DOI:10.5388/aon.2019.19.2.81
|
|
|
[2]
|
The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review
BMC Cancer,
2018
DOI:10.1186/s12885-018-4185-0
|
|
|
[3]
|
Role of metformin in oxaliplatin-induced peripheral neuropathy in patients with stage III colorectal cancer: randomized, controlled study
International Journal of Colorectal Disease,
2018
DOI:10.1007/s00384-018-3104-9
|
|
|
[4]
|
Noradrenergic inhibition of spinal hyperexcitation elicited by cutaneous cold stimuli in rats with oxaliplatin-induced allodynia: electrophysiological and behavioral assessments
The Journal of Physiological Sciences,
2017
DOI:10.1007/s12576-016-0505-9
|
|
|
[5]
|
Reliability testing of oxaliplatin-associated neurotoxicity questionnaire (OANQ), a pilot study
Supportive Care in Cancer,
2016
DOI:10.1007/s00520-015-2838-y
|
|
|